510(k) Report

510(k) · Cleared

Cleared

D3 Ultra Dfa Respiratory Virus Screening & ID Kit

K061101510(k) TraditionalCleared Nov 20, 2006214-day reviewClass I21 CFR 866.3330

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Diagnostic Hybrids, Inc. · GNW Antisera, Cf, Influenza Virus A, B, C

Cleared on Nov 20, 2006 as substantially equivalent to K022713 (Diagnostic Hybrids, Inc., 2002) after a 214-day review. Its family tree reaches back 1 generation to 2002. 7 later devices descend from it.

Decided
Nov 20, 2006
Review
214 days
Class
Class I
Product code
GNW
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K022713 (2002). 7 later devices descend from it, 7 citing it directly.

Descendants, by year cleared 2009: 5 descendants cleared2008: 2 descendants clearedK022713 · Dfa Respiratory Virus Screening & ID Kit · Diagnostic Hybrids, Inc. · 2002200020052010201520202025
Descendants, by generation 1 generation forward: 7 descendants K022713 · Dfa Respiratory Virus Screening & ID Kit · Diagnostic Hybrids, Inc. · 20020
  1. Root · 1 generation backK022713 Dfa Respiratory Virus Screening & ID KitDiagnostic Hybrids, Inc. · 2002
  2. This deviceK061101 D3 Ultra Dfa Respiratory Virus Screening & ID KitDiagnostic Hybrids, Inc. · 2006
  3. Descendant · cites it directly · 4 of its ownK081928 D3 Duet Dfa RSV/Respiratory Virus Screening KitDiagnostic Hybrids, Inc. · 2008
  4. Descendant · cites it directly · 0 of its ownK093415 D3 Fastpoint L-Dfa Parainfluenza Virus/Adenovirus Identification KitDiagnostic Hybrids, Inc. · 2009
  5. Descendant · cites it directly · 0 of its ownK093233 D3 Fastpoint L-Dfa RSV/MVP Identification KitDiagnostic Hybrids, Inc. · 2009
  6. Descendant · cites it directly · 0 of its ownK092882 D3 Fastpoint L-Dfa Influenza a/Influenza B Virus Identification KitDiagnostic Hybrids, Inc. · 2009
  7. Descendant · cites it directly · 0 of its ownK091171 D3 Ultra Duet Dfa Respiratory Virus Identification KitDiagnostic Hybrids, Inc. · 2009

Showing 5 of 7 descendants. See all descendants

Descendants cleared per year

2008: 22009: 5
2008high 5 (2009) · low 0 (2010)2026

Most influential descendants

Showing 5 of 7 · See all
  • K081928D3 Duet Dfa RSV/Respiratory Virus Screening KitDiagnostic Hybrids, Inc. · 2008 · cites it directly4descendants
  • K093415D3 Fastpoint L-Dfa Parainfluenza Virus/Adenovirus Identification KitDiagnostic Hybrids, Inc. · 2009 · cites it directly0descendants
  • K093233D3 Fastpoint L-Dfa RSV/MVP Identification KitDiagnostic Hybrids, Inc. · 2009 · cites it directly0descendants
  • K092882D3 Fastpoint L-Dfa Influenza a/Influenza B Virus Identification KitDiagnostic Hybrids, Inc. · 2009 · cites it directly0descendants
  • K091171D3 Ultra Duet Dfa Respiratory Virus Identification KitDiagnostic Hybrids, Inc. · 2009 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K022713Dfa Respiratory Virus Screening & ID KitDiagnostic Hybrids, Inc.2002—
0 (this device)K061101D3 Ultra Dfa Respiratory Virus Screening & ID KitDiagnostic Hybrids, Inc.2006—
+1K081928D3 Duet Dfa RSV/Respiratory Virus Screening KitDiagnostic Hybrids, Inc.2008—
+1K093415D3 Fastpoint L-Dfa Parainfluenza Virus/Adenovirus Identification KitDiagnostic Hybrids, Inc.2009—
+1K093233D3 Fastpoint L-Dfa RSV/MVP Identification KitDiagnostic Hybrids, Inc.2009—
+1K092882D3 Fastpoint L-Dfa Influenza a/Influenza B Virus Identification KitDiagnostic Hybrids, Inc.2009—
+1K091171D3 Ultra Duet Dfa Respiratory Virus Identification KitDiagnostic Hybrids, Inc.2009—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200820
200950
FIG. 1 — Lineage of K061101, 2002–2009Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GNW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K022713Dfa Respiratory Virus Screening & ID Kit
Summary page 3
…azide. J. Substantial Equivalence Information: 1. Predicate device name(s): DFA Respiratory Virus Screening & ID Kit 2. Predicate 5 10(k) number(s): K022713 3. Comparison with predicate: The similarities to predicate device are in indicated use, operating principle, basic…
Diagnostic Hybrids, Inc.2002—

What descends from it? (7)

7 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K081928D3 Duet Dfa RSV/Respiratory Virus Screening KitDiagnostic Hybrids, Inc.20084
K093415D3 Fastpoint L-Dfa Parainfluenza Virus/Adenovirus Identification KitDiagnostic Hybrids, Inc.20090
K093233D3 Fastpoint L-Dfa RSV/MVP Identification KitDiagnostic Hybrids, Inc.20090
K092882D3 Fastpoint L-Dfa Influenza a/Influenza B Virus Identification KitDiagnostic Hybrids, Inc.20090
K091171D3 Ultra Duet Dfa Respiratory Virus Identification KitDiagnostic Hybrids, Inc.20090
K092300Modification to D3 Ultra Dfa Respiratory Virus Screening & ID KitDiagnostic Hybrids, Inc.20090
K081746D3 Duet Dfa Influenza a/Respiratory Virus Screening KitDiagnostic Hybrids, Inc.20080

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K081928 (Diagnostic Hybrids, Inc., 2008) has gone furthest, with 4 descendants of its own.

How does its category compare?

All GNW devices

GNW Antisera, Cf, Influenza Virus A, B, C: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GNW

2in 2009

2008: 12009: 2
2007high 2 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GNW

Too few GNW 510(k)s in any year since 2007 to give a median.

Recalls per year · GNW

2in 2008

2008: 2
2007high 2 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GNW

No MAUDE report names GNW since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20081—20
20092—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The Diagnostic Hybrids, Inc.'s D 3 Ultra DFA (direct fluorescent antibody) RESPIRATORY VIRUS SCREENING & ID KIT is intended for the qualitative detection and identification of the Influenza A, Influenza B, Respiratory Syncytial Virus (RSV), Adenovirus, Parainfluenza 1, Parainfluenza 2 and Parainfluenza 3 virus in respiratory specimens, by either direct detection or cell culture method, by immunofluorescence using fluoresceinated monoclonal antibodies…

Read the full statement (107 words)

The Diagnostic Hybrids, Inc.'s D 3 Ultra DFA (direct fluorescent antibody)

RESPIRATORY VIRUS SCREENING & ID KIT is intended for the qualitative detection

and identification of the Influenza A, Influenza B, Respiratory Syncytial Virus (RSV),

Adenovirus, Parainfluenza 1, Parainfluenza 2 and Parainfluenza 3 virus in respiratory

specimens, by either direct detection or cell culture method, by immunofluorescence

using fluoresceinated monoclonal antibodies (MAbs). It is recommended that

specimens found to be negative after examination of the direct specimen result be

confirmed by cell culture. Negative results do not preclude respiratory virus infection

and should not be used as the sole basis for diagnosis, treatment or other management

decisions.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K061101: D3 Ultra Dfa Respiratory Virus Screening & ID Kit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K061101

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026